Dr. Kevin P. Ridenhour is an expert in the field of Hematology. He researched medicine at Brody School of Medicine at East Carolina University. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Kevin Ridenhour is a published doctor and has 1 publication published. The lastest was: 'Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.' He accepts all Medicare patients.
NPI NUMBER | 1568462059 | |
NPPES Provider LastName | RIDENHOUR | |
NPPES Provider FirstName | KEVIN | |
NPPES Provider ZIPCode | 423030839 | |
NPPES Provider State | KY | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 729.0 | |
Distinct Opioid Count | 4.0 | |
Opioid Claim Count | 111.0 | |
Percent Opioid Claims | 15.23 |
National Provider Identifier [NPI] | 1568462059 |
Last Name Of The Provider | RIDENHOUR |
First Name Of The Provider | KEVIN |
View All |
Dr. James R. Thomas, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Jewraj G. Maheshwari, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |